Microbicide Trials Network

MTN-008 Study Specific Procedures (SSPs) Manual

DescriptionDateSize
Individual Sections
Overview and Version Control2012-Dec-1251.87 KB
Table of Contents2011-Nov-1535.72 KB
01: Introduction2011-Mar-2443 KB
02: Protocol2011-Mar-241.16 MB
03: Documentation2011-Mar-24127.71 KB
04: Accrual v1.42012-Mar-02900.18 KB
05: Informed Consent2011-Mar-24194.4 KB
06: Follow-up v1.32012-Dec-22331.06 KB
07: Visit Checklists2011-Jan-0121.46 KB
08: Particpant Rentention2011-Mar-2436.11 KB
09: Study Product v1.12011-May-05118.5 KB
10: Clinical Considerations v1.12011-May-05184.07 KB
11: Adverse Event Reporting and Safety Monitoring v1.32011-Nov-15192.08 KB
12: Laboratory Considerations v1.22011-Aug-19485.35 KB
13: Behavioral Assessments2011-Mar-2478.11 KB
14: Data Collection2011-Mar-241.34 MB
15: Data Communiques2011-Mar-247.96 KB
15: Data Communiques #12011-Apr-0582.21 KB
15: Data Communiques #22011-May-0573.91 KB
15: Data Communiques #32011-May-2680.71 KB
15: Data Communiques #42011-Oct-0476.94 KB
15: Data Communiques #52011-Oct-2068.42 KB
15: Data Communiques #62012-Feb-0866.58 KB
15: Data Communiques #72013-May-16534.19 KB
16: Study Reporting Plan2011-Mar-2417.96 KB
Section Archive: Retired Section Versions
04: Accrual v1.02011-Mar-242.38 MB
04: Accrual v1.12011-Apr-181.01 MB
04: Accrual v1.22011-Aug-261.02 MB
04: Accrual v1.32011-Nov-151.05 MB
06: Follow-up v1.02011-Mar-24213.9 KB
06: Follow-up v1.12011-Apr-18217.11 KB
06: Follow-up v1.22011-May-18121.45 KB
09: Study Product v1.02011-Mar-24391.27 KB
10: Clinical Considerations v1.02011-Mar-24251.26 KB
11: Adverse Event Reporting and Safety Monitoring v1.02011-Mar-24199.61 KB
11: Adverse Event Reporting and Safety Monitoring v1.12011-Jun-16124.53 KB
11: Adverse Event Reporting and Safety Monitoring v1.22011-Aug-24191.95 KB
12: Laboratory Considerations v1.02011-Apr-11587.55 KB
12: Laboratory Considerations v1.12011-May-04484 KB